Sunday, September 20, 2026

Canaan Stock Plummets 31% In 21 Sessions: Is It Time To Sell?

ViaNews Editorial Team

September 11, 2023

Canaan Stock Plummets 31% In 21 Sessions: Is It Time To Sell?

(VIANEWS) - Canaan (NASDAQ:CAN) shares have fallen by 31.65% over 21 trading sessions, from EUR2.78 on August 10th to EUR1.90 at 10:55 EST on Monday morning. This decline follows on the previous session's downward trend and follows suit with the previous NASDAQ index's gain of 0.52% to EUR13,832.40 following yesterday's rise; Canaan's last closing price was EUR1.89 which represents 52.51% off its 52-week high of EUR3.98.

About Canaan

Canaan Inc is a premier designer and manufacturer of IC final mining equipment for bitcoin mining. Their operations span China, the US, Australia, Kazakhstan, Hong Kong Canada Mainland China Thailand Sweden. Established in 2013 the company's main office is based out of Singapore where they provide assembly distribution spare parts services for their innovative products.

Yearly Analysis

Canaan's stock currently trades at EUR1.90, below its 52-week high of EUR3.98 but above its 52-week low of EUR1.83. Canaan anticipates experiencing negative sales growth of 66.8% this year and then recovering with 51.1% growth the following year. Canaan currently has an EBITDA ratio of -2.02, which indicates negative earnings prior to accounting for interest, taxes, depreciation and amortization expenses. Given this information, investors should exercise extreme caution before investing in Canaan's stock. With negative sales growth and EBITDA figures suggesting financial distress at Canaan, and its current trading price below its 52-week high possibly signalling market sentiment against Canaan; however, its price being above 52-week low suggests market optimism regarding Canaan's potential growth prospects in future. As such, investors must conduct further investigation of Canaan before making investment decisions.

Technical Analysis

Canaan stock has been experiencing difficulty maintaining its value, with current worth considerably below both its 50-day and 200-day moving averages of EUR2.54 and EUR2.61, indicating an ongoing downward trend over both time periods. Furthermore, its volume has drastically declined from its average of 3043960; yesterday's last reported volume was only 272140 representing a decrease of 92.08% - this may contribute to its volatility and instability. Canaan has experienced historically negative intraday variation averages over the last week, month and quarter; its average volatility peaked at 2.11% for last week, 4.47% for month and 4.19% for quarter. According to Canaan's stochastic oscillator, its stock may currently be considered overbought (>=80), indicating potential signs of overspending in the near future. Canaan appears to be facing difficulties with momentum and volatility, making its stock a potentially risky investment.

Quarter Analysis

Canaan's latest quarter sales growth is negative 81.3% and its projected next-quarter growth estimate is negative 17.7%; overall Canaan estimates for its current quarter are estimated at negative 285.7% which indicates significant downward momentum; however, their estimate for next-quarter growth suggests positive 26.9% which could provide hope of future success for Canaan. Canaan has experienced year-on-year quarterly revenue growth that has fallen by 72.6% year over year with twelve trailing months totaling 490.93M - this marks a substantial drop from last year. Overall, Canaan's current financial status appears daunting; however, there are signs of hope in its near future. Investors should carefully evaluate this information prior to making any investment decisions.

Equity Analysis

Based on Canaan's trailing twelve month earnings per share (EPS) is EUR-0.47, indicating it is not producing profits for shareholders at present. Furthermore, Canaan's return on equity (ROE) over this timeframe stands at negative -13.4% which suggests they are failing to use shareholder's equity efficiently enough in order to generate profits for themselves. Investors should proceed with caution when investing in Canaan, as negative EPS and ROE indicators could suggest financial instability or lack of profitability. Before making their decision to invest in Canaan, it may be worthwhile conducting further research on its financials, industry trends, management team and potential positive factors which could mitigate these indicators of negative returns.

More news about Canaan (CAN).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com